{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:54:47Z","timestamp":1794696887229,"version":"4.9.1"},"reference-count":18,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,3,7]],"date-time":"2007-03-07T00:00:00Z","timestamp":1173225600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine the incidence of <jats:italic>Isospora belli<\/jats:italic> infection in HIV\u2010infected patients in France, and to study risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The French Hospital Database on HIV (FHDH) is a prospective cohort study that collects demographic, clinical and therapeutic data on patients managed in 62 hospitals. We reviewed all cases of <jats:italic>I. belli<\/jats:italic> infection recorded between 1992 and 2003. We compared the incidence in 1992\u20131994 [before the use of dual therapy and combination antiretroviral therapy (cART)] and in 1997\u20132003 (when use of cART was widespread), after stratification for CD4 cell count (&lt; 50, 50\u201399, 100\u2013199 and &gt; 200 cells\/\u03bcL).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 164 patients had <jats:italic>I. belli<\/jats:italic> infection either at enrolment (<jats:italic>n<\/jats:italic>=71) or during follow up (<jats:italic>n<\/jats:italic>=93). During the study period, <jats:italic>I. belli<\/jats:italic> infection tended to occur less frequently during follow up, and to be diagnosed mainly at database enrolment. The incidence of <jats:italic>I. belli<\/jats:italic> infection during follow up fell by 79% [relative hazard (RH) 0.21; 95% confidence interval (CI) 0.13\u20130.33] in the cART period compared with the pre\u2010cART period; no such change was noted among patients with CD4 cell counts below 50 cells\/\u03bcL. In multivariable analysis, the risk of <jats:italic>I. belli<\/jats:italic> infection was significantly higher among patients from sub\u2010Saharan Africa (RH 4.3; 95% CI 2.6\u20137.3). After adjustment for CD4 cell count, patients receiving cotrimoxazole prophylaxis were found to be at a lower risk of <jats:italic>I. belli<\/jats:italic> infection (RH 0.3; 95% CI 0.2\u20130.6).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In France, <jats:italic>I. belli<\/jats:italic> infection among HIV\u2010infected patients is now mainly seen in patients from sub\u2010Saharan Africa, who present at an advanced stage.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2007.00441.x","type":"journal-article","created":{"date-parts":[[2007,3,7]],"date-time":"2007-03-07T19:19:42Z","timestamp":1173295182000},"page":"124-130","source":"Crossref","is-referenced-by-count":21,"title":["HIV\u2010associated <i>Isospora belli<\/i> infection: incidence and risk factors in the French Hospital Database on HIV"],"prefix":"10.1111","volume":"8","author":[{"given":"M","family":"Guiguet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Furco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Tattevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u2010M","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the French Hospital Database on HIV Clinical Epidemiology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,3,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh438"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200010010-00006"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199811000-00026"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199910010-00017"},{"key":"e_1_2_6_6_2","first-page":"134","article-title":"The changing pattern of AIDS\u2010defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic","volume":"42","author":"Ives N","year":"2001","journal-title":"J Infect Dis"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/515191"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/320894"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-11-200006060-00006"},{"key":"e_1_2_6_10_2","first-page":"1024","article-title":"Prevalence of intestinal protozoans in French patients infected with HIV","volume":"6","author":"Cotte L","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)01034-3"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1995.53.656"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/367655"},{"key":"e_1_2_6_14_2","first-page":"211","article-title":"Intestinal parasitic infections in HIV\/AIDS patients","volume":"37","author":"Silva C","year":"2005","journal-title":"experience at a teaching hospital in central Brazil"},{"key":"e_1_2_6_15_2","first-page":"217","article-title":"Isosporiasis in Venezuelan adults infected with human immunodeficiency virus","volume":"69","author":"Certad G","year":"2003","journal-title":"clinical characterization"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-6-200009190-00007"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","unstructured":"LanoyE Mary\u2010KrauseM TattevinPet al.Frequency determinants and consequences of delayed access to care for HIV patients in France. Antivir Ther2007;12:89\u201396.","DOI":"10.1177\/135965350701200111"},{"key":"e_1_2_6_18_2","first-page":"1463","article-title":"Early chemoprophylaxis with trimetoprim\u2010sulphamethoxazole for HIV\u20101\u2010infected adults in Abidjan, C\u00f4te d'Ivoire","volume":"353","author":"Anglaret X","year":"1999","journal-title":"a randomised trial"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/321901"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2007.00441.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2007.00441.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T02:18:28Z","timestamp":1696904308000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2007.00441.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1111\/j.1468-1293.2007.00441.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2007.00441.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}